Study of the quality of life and adherence to treatment in patients from 2 to 16 years-old with type 1 diabetes mellitus in Andalusia, Spain

Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type

“…Recently, we reported that in children and adolescents, the perceived benefits of CGM use were associated with TIR and reduced glucose variability, regardless of the technology used, and here we speculate that in the same subjects, CGM satisfaction is the key factor related to QoL. Other studies have analysed real‐world clinical but not psychological outcomes related to different technology modalities in T1D, 25–28 and a recent survey of youths between 2 and 16 years of age analysed HRQoL, but only 16.8% of them used a CGM 29 …”

“…Other studies have analysed real-world clinical but not psychological outcomes related to different technology modalities in T1D, [25][26][27][28] and a recent survey of youths between 2 and 16 years of age analysed HRQoL, but only 16.8% of them used a CGM. 29 The KINDL questionnaire adopted here to measure generic aspects of QoL (physical health, emotional and school functioning), combined with the assessment of diabetes-specific dimensions, provided a more comprehensive analysis of satisfaction, health, well-being and burden commonly associated with the management of diabetes, expanding knowledge about the relationship between CGM satisfaction and QoL. Considering that children and adolescents with T1D are at increased risk of developing psychological problems, 30 these results underscore how perceived satisfaction regarding CGM has a relevant role in the well-being of children and adolescents with T1D and their families.…”

Confirmatory Factor Structure of Treatment Adherence in the Covid-19 Era

“…Casaño et to the., demonstrated that treatment adherence is related to the quality of life. L expectations as triggers of risk are beliefs and intentions about a disease [8]. In this sense, the present study explains the uncertain attitudes towards respiratory diseases in relation to the groups in which the individuals are immersed.…”

A Quick Look at the Present and Immediate Future of Type 1 DM

“…Without a doubt, the greatest current advances in the treatment of DM1 come from the use of technology, together with regulated/structured and continued diabetes education, this being a fundamental piece to improve control, adherence to treatment and quality. of patients' lives [2]. Despite all the advances, in general the objectives advocated by international societies for this age (American Diabetes Association [ADA], International Society for Pediatric and Adolescent Diabetes [ISPAD]) are not achieved, leading to the search for other systems that lead to greater adherence to treatment.…”